Cargando…
Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
Patient assessment of disease activity in rheumatoid arthritis (RA) may be useful in clinical practice, offering a patient-friendly, location independent, and a time-efficient and cost-efficient means of monitoring the disease. The objective of this study was to identify patient-reported outcome mea...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013514/ https://www.ncbi.nlm.nih.gov/pubmed/27651921 http://dx.doi.org/10.1136/rmdopen-2015-000202 |
_version_ | 1782452182041231360 |
---|---|
author | Hendrikx, Jos de Jonge, Marieke J Fransen, Jaap Kievit, Wietske van Riel, Piet LCM |
author_facet | Hendrikx, Jos de Jonge, Marieke J Fransen, Jaap Kievit, Wietske van Riel, Piet LCM |
author_sort | Hendrikx, Jos |
collection | PubMed |
description | Patient assessment of disease activity in rheumatoid arthritis (RA) may be useful in clinical practice, offering a patient-friendly, location independent, and a time-efficient and cost-efficient means of monitoring the disease. The objective of this study was to identify patient-reported outcome measures (PROMs) to assess disease activity in RA and to evaluate the measurement properties of these measures. Systematic literature searches were performed in the PubMed and EMBASE databases to identify articles reporting on clinimetric development or evaluation of PROM-based instruments to monitor disease activity in patients with RA. 2 reviewers independently selected articles for review and assessed their methodological quality based on the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) recommendations. A total of 424 abstracts were retrieved for review. Of these abstracts, 56 were selected for reviewing the full article and 34 articles, presenting 17 different PROMs, were finally included. Identified were: Rheumatoid Arthritis Disease Activity Index (RADAI), RADAI-5, Patient-based Disease Activity Score (PDAS) I & II, Patient-derived Disease Activity Score with 28-joint counts (Pt-DAS28), Patient-derived Simplified Disease Activity Index (Pt-SDAI), Global Arthritis Score (GAS), Patient Activity Score (PAS) I & II, Routine Assessment of Patient Index Data (RAPID) 2–5, Patient Reported Outcome-index (PRO-index) continuous (C) & majority (M), Patient Reported Outcome CLinical ARthritis Activity (PRO-CLARA). The quality of reports varied from poor to good. Typically 5 out of 10 clinimetric domains were covered in the validations of the different instruments. The quality and extent of clinimetric validation varied among PROMs of RA disease activity. The Pt-DAS28, RADAI, RADAI-5 and RAPID 3 had the strongest and most extensive validation. The measurement properties least reported and in need of more evidence were: reliability, measurement error, cross-cultural validity and interpretability of measures. |
format | Online Article Text |
id | pubmed-5013514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50135142016-09-20 Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis Hendrikx, Jos de Jonge, Marieke J Fransen, Jaap Kievit, Wietske van Riel, Piet LCM RMD Open Review Patient assessment of disease activity in rheumatoid arthritis (RA) may be useful in clinical practice, offering a patient-friendly, location independent, and a time-efficient and cost-efficient means of monitoring the disease. The objective of this study was to identify patient-reported outcome measures (PROMs) to assess disease activity in RA and to evaluate the measurement properties of these measures. Systematic literature searches were performed in the PubMed and EMBASE databases to identify articles reporting on clinimetric development or evaluation of PROM-based instruments to monitor disease activity in patients with RA. 2 reviewers independently selected articles for review and assessed their methodological quality based on the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) recommendations. A total of 424 abstracts were retrieved for review. Of these abstracts, 56 were selected for reviewing the full article and 34 articles, presenting 17 different PROMs, were finally included. Identified were: Rheumatoid Arthritis Disease Activity Index (RADAI), RADAI-5, Patient-based Disease Activity Score (PDAS) I & II, Patient-derived Disease Activity Score with 28-joint counts (Pt-DAS28), Patient-derived Simplified Disease Activity Index (Pt-SDAI), Global Arthritis Score (GAS), Patient Activity Score (PAS) I & II, Routine Assessment of Patient Index Data (RAPID) 2–5, Patient Reported Outcome-index (PRO-index) continuous (C) & majority (M), Patient Reported Outcome CLinical ARthritis Activity (PRO-CLARA). The quality of reports varied from poor to good. Typically 5 out of 10 clinimetric domains were covered in the validations of the different instruments. The quality and extent of clinimetric validation varied among PROMs of RA disease activity. The Pt-DAS28, RADAI, RADAI-5 and RAPID 3 had the strongest and most extensive validation. The measurement properties least reported and in need of more evidence were: reliability, measurement error, cross-cultural validity and interpretability of measures. BMJ Publishing Group 2016-08-18 /pmc/articles/PMC5013514/ /pubmed/27651921 http://dx.doi.org/10.1136/rmdopen-2015-000202 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Review Hendrikx, Jos de Jonge, Marieke J Fransen, Jaap Kievit, Wietske van Riel, Piet LCM Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title | Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title_full | Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title_fullStr | Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title_full_unstemmed | Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title_short | Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis |
title_sort | systematic review of patient-reported outcome measures (proms) for assessing disease activity in rheumatoid arthritis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013514/ https://www.ncbi.nlm.nih.gov/pubmed/27651921 http://dx.doi.org/10.1136/rmdopen-2015-000202 |
work_keys_str_mv | AT hendrikxjos systematicreviewofpatientreportedoutcomemeasurespromsforassessingdiseaseactivityinrheumatoidarthritis AT dejongemariekej systematicreviewofpatientreportedoutcomemeasurespromsforassessingdiseaseactivityinrheumatoidarthritis AT fransenjaap systematicreviewofpatientreportedoutcomemeasurespromsforassessingdiseaseactivityinrheumatoidarthritis AT kievitwietske systematicreviewofpatientreportedoutcomemeasurespromsforassessingdiseaseactivityinrheumatoidarthritis AT vanrielpietlcm systematicreviewofpatientreportedoutcomemeasurespromsforassessingdiseaseactivityinrheumatoidarthritis |